2Scott BK,Christian GR,Pat M,et al.Protocolized anemia management with erythropoietin in hemodialysis patients:A randomized controlled trial[J].J Am Soc Nephrol,2003,14:2654-2661.
3Stephanie H,Ross MA,Carol M,et al.A multidisciplinary approach to the control of the calcium phosphate product[J].Dialysis and Transplantation,1999,28:309-313.
5[2]Rostand SG, Rutsky EA. Cardiac disease in dialysis patients[M]. 2nd ed, In: Nissenson AR, Fine NR. Clinical Dialysis. Norwalk: Appleton & Hange, 1990. 409～446.
6Cocchi R,Esposti ED,Fabbri A,et al.Prevalence of hypertensin in patients on peritoneal dialysis:results of an Italian multicentre study [J].Nephrol Dial Transplant,1999,14:1536 - 1540
7Cheigh JS,Kim H.Hypertension in continuous ambulatory peritoneal dialysis patients:what do we know and what can we do about it[J] ?Perit Dial Int,1999,19 (suppl 2):S138 -143
8Faller B,Lameire N.Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years [J].Nephrol Dial Transplant,1994,9:280 - 286
9De Vecchi A,Maccario M,Scalamogna A,et al.Nine patients treated for more than 10 years with continuous ambulatory peritoneal dialysis[J].Am J Nephrol,1996,16:455 -461
10Diane LF,Curtis AJ.Current management of anemia in adult hemodialysis patients with end-stage renal disease [J].Am J Health Syst Pharm,2002,59:429-435
